IBA catalog GB int60p 10 v9 - IBA Molecular

INTERNATIONAL CATALOGUE ALOGUE
NEUROLITE ®
Kit for the preparation of technetium ( 99m Tc) bicisate injection
Vial A
Bicisate dihydrochloride 900 µg
Stannous Chloride dihydrate
Disodium edetate, Mannitol, Hydrochloric acid
Nitrogen (headspace)
Vial B
Disodium phosphate heptahydrate
(Na 2 HPO4 • 7H 2 O)
Sodium dihydrogen phosphate monohydrate
(NaH 2 PO4 • 1H 2 O)
Water for injection
Volume of 99m Tc pertechnetate to add in vial B 2 ml
Radiochemical purity > 90%
Indications /Posology Tc-99m Bicisate scintigraphy is indicated in the evaluation of
regional cerebral perfusion abnormalities in adult patients with
central nervous system disorders
The recommended dose for intravenous injection is 740 MBq
(20 mCi) in the average patient (70 kg)
Time between injection and examination Within 6h
Storage 18 months
Activity per vial 3700 MBq (100 mCi)
Stability of labelled product 8h at < 25°C
Availability From stock
Number of radiolabelled preparations per kit 5
OSTEOCIS ®
Kit for the preparation of technetium ( 99m Tc) Oxidronate injection
Each vial contains :
Sodium oxidronate (HMDP) 3.0 mg
Stannous chloride dihydrate
Ascorbic acid
Sodium chloride
Under nitrogen atmosphere
Volume of pertechnetate 99m Tc
to use for reconstitution 2 to 10 ml
Radiochemical purity � 95 %
Storage 12 months at 2 to 8°C
Activity per vial 0.74 to 11.1 GBq
Indications / Posology Bone scintigraphy
500 MBq
300 to 700 MBq / 50 or 70kg adult
After reconstitution with sodium pertechnetate ( 99m Tc) solution, the
agent may be used for bone scintigraphy, where it delineates
areas of altered osteogenesis
Stability of labelled product 8h at 2 - 8ºC
Time between injection and examination not earlier than 2h after injection
Availability From stock
Number of radiolabelled preparations per kit 5
30 | IBA |
IMPORTANT : Read package leaflet before using the kit
“Availability of the products, in the different countries, according to the registration status”